Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor VIII Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01562457
What this trial is testing

Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 30
Not applicableNot Yet RecruitingNCT07653139
What this trial is testing

Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany

Who this might be right for
Haemophilia A
Novo Nordisk A/S 150
Not applicableActive Not RecruitingNCT04158934
What this trial is testing

A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 207
Large-scale testing (Phase 3)Study completedNCT02246881
What this trial is testing

Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.

Who this might be right for
Von Willebrand Disease
Bio Products Laboratory
Not applicableStudy completedNCT03818529
What this trial is testing

ATHN 8: Previously Untreated Patients (PUPs) Matter Study

Who this might be right for
HemophiliaHemophilia AHemophilia B+5 more
American Thrombosis and Hemostasis Network 237
Large-scale testing (Phase 3)Study completedNCT02548143
What this trial is testing

LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures

Who this might be right for
Hemophilia
Laboratoire français de Fractionnement et de Biotechnologies 12
Post-approval studies (Phase 4)Study completedNCT03449342
What this trial is testing

Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 60
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Early research (Phase 1)Study completedNCT01228669
What this trial is testing

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+1 more
Novo Nordisk A/S 52
Not applicableStudy completedNCT02093741
What this trial is testing

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

Who this might be right for
Hemophilia ACongenital Factor VIII (FVIII) Deficiency
Baxalta now part of Shire 65
Not applicableStudy completedNCT03372993
What this trial is testing

Prospective, Non-interventional Study to Evaluate Immunogenicity of AryoSeven

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency+1 more
AryoGen Pharmed Co. 200
Not applicableStudy completedNCT01159587
What this trial is testing

Prophylaxis Versus On-demand Therapy Through Economic Report

Who this might be right for
Hemophilia A
Bayer 58
Not applicableStudy completedNCT00341705
What this trial is testing

The Second Multicenter Hemophilia Cohort Study

Who this might be right for
Liver DecompensationHepatocellular CarcinomaNon-Hodgkin Lymphoma
National Cancer Institute (NCI) 2,565
Large-scale testing (Phase 3)Active Not RecruitingNCT05135559
What this trial is testing

A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors

Who this might be right for
Haemophilia A and B With and Without Inhibitors
Novo Nordisk A/S 153
Post-approval studies (Phase 4)Study completedNCT01800435
What this trial is testing

A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor

Who this might be right for
Hereditary Factor VIII Deficiency Disease With Inhibitor
Oslo University Hospital 6
Not applicableStudy completedNCT02190149
What this trial is testing

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 64
Testing effectiveness (Phase 2)Study completedNCT04188639
What this trial is testing

Emicizumab in Acquired Hemophilia A

Who this might be right for
Hemophilia A, Acquired
GWT-TUD GmbH 47
Not applicableLooking for participantsNCT06684314
What this trial is testing

Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

Who this might be right for
Hemophilia A
Sanofi 100
Large-scale testing (Phase 3)Ended earlyNCT00306670
What this trial is testing

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

Who this might be right for
Hemophilia A
Georgetown University 2
Early research (Phase 1)Study completedNCT01708564
What this trial is testing

A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B

Who this might be right for
Hemophilia
rEVO Biologics 15
Next Page